Virtu Financial LLC Takes Position in Doximity, Inc. (NASDAQ:DOCS)

Virtu Financial LLC purchased a new stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 16,577 shares of the company's stock, valued at approximately $885,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. FMR LLC increased its holdings in Doximity by 30.5% in the 3rd quarter. FMR LLC now owns 6,837,733 shares of the company's stock worth $297,920,000 after buying an additional 1,598,602 shares during the period. State Street Corp grew its position in Doximity by 2.5% during the 3rd quarter. State Street Corp now owns 3,693,982 shares of the company's stock worth $160,947,000 after purchasing an additional 88,922 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Doximity by 19.8% in the 3rd quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company's stock valued at $124,503,000 after buying an additional 472,565 shares during the period. Los Angeles Capital Management LLC grew its holdings in Doximity by 33.7% during the fourth quarter. Los Angeles Capital Management LLC now owns 870,322 shares of the company's stock worth $46,466,000 after acquiring an additional 219,448 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its position in Doximity by 3.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 778,524 shares of the company's stock valued at $41,565,000 after acquiring an additional 25,523 shares in the last quarter. Hedge funds and other institutional investors own 87.19% of the company's stock.

Remove Ads

Analyst Ratings Changes

Several research firms have recently weighed in on DOCS. Needham & Company LLC lifted their target price on shares of Doximity from $65.00 to $82.00 and gave the company a "buy" rating in a report on Friday, February 7th. Stephens started coverage on Doximity in a report on Friday, December 20th. They issued an "equal weight" rating and a $55.00 price target for the company. Canaccord Genuity Group raised their price objective on Doximity from $60.00 to $71.00 and gave the company a "hold" rating in a report on Friday, February 7th. The Goldman Sachs Group boosted their target price on shares of Doximity from $58.00 to $80.00 and gave the stock a "neutral" rating in a research note on Monday, February 10th. Finally, Leerink Partners raised shares of Doximity from a "market perform" rating to an "outperform" rating and raised their price target for the stock from $60.00 to $90.00 in a research note on Friday, February 7th. Eleven research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, Doximity currently has a consensus rating of "Moderate Buy" and a consensus target price of $64.22.

Insider Activity

In related news, Director Timothy S. Cabral sold 20,000 shares of the business's stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the transaction, the director now directly owns 6,360 shares of the company's stock, valued at $366,463.20. The trade was a 75.87 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 37.40% of the company's stock.

Doximity Stock Performance

Shares of DOCS traded down $2.15 during midday trading on Friday, hitting $58.40. 2,279,418 shares of the stock were exchanged, compared to its average volume of 1,947,026. The stock has a fifty day simple moving average of $65.39 and a 200 day simple moving average of $54.15. Doximity, Inc. has a 52-week low of $22.96 and a 52-week high of $85.21. The firm has a market cap of $10.90 billion, a P/E ratio of 58.40, a P/E/G ratio of 4.10 and a beta of 1.34.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.